Salary
Location
Mexico, Mexico City
Location
Mexico City
Remote Working
Office Based
Job Categories
Drug Safety
Job Type
Permanent
Description
We are currently seeking a Senior Pharmacovigilance Reporting Associate to join our diverse and dynamic team. As a Senior Pharmacovigilance Reporting Associate at ICON, you will be essential in ensuri
Reference
JR129330
Expiry date
01/01/0001
Read more
Shortlist Save this role
Salary
Location
Mexico, Mexico City
Location
Mexico City
Remote Working
Hybrid: Office/Remote
Job Categories
Drug Safety
Job Type
Permanent
Description
We are currently seeking a Pharmacovigilance Reporting Associate/Senior Associate(Leader role) to join our diverse and dynamic team!-Location: Mexico City (office-based an average of 3 days per week)
Reference
JR129080
Expiry date
01/01/0001
Read more
Shortlist Save this role
Salary
Location
Mexico, Mexico City
Location
Mexico City
Remote Working
Hybrid: Office/Remote
Job Categories
Drug Safety
Job Type
Permanent
Description
We are currently seeking a Senior Pharmacovigilance Systems Associate to join our diverse and dynamic team. As a Senior Pharmacovigilance Systems Associate at ICON, you will be pivotal in managing and
Reference
JR128071
Expiry date
01/01/0001
Read more
Shortlist Save this role
.png)
Teaser label
IndustryContent type
BlogsPublish date
05/22/2025
Summary
World Schizophrenia Awareness Day 2025 Every year on 24 May, World Schizophrenia Awareness Day offers a vital opportunity to raise awareness, dismantle stigma, and celebrate the strength of individ
.png)
Teaser label
Inside ICONContent type
BlogsPublish date
05/08/2025
Summary
Standing Strong on Ovarian Cancer Day: ICON's Commitment to Advancing Care Ovarian cancer remains one of the most challenging gynaecologic malignancies, both in terms of detection and treatmen
.png)
Teaser label
IndustryContent type
BlogsPublish date
05/07/2025
Summary
Patient Centricity in Clinical Research: What it is and Why it Matters In the past, clinical research was designed around the needs of sponsors, researchers, and regulatory bodies. Patients were of